Ataraxis AI Launches Test to Predict Response to Neoadjuvant Therapy in Breast Cancer
The tool uses digitized pathology slides to estimate how patients will respond to therapy before surgery.
Category: Breast
Breast
Latest
Breast
Latest
Roche Gains FDA Approval for Expanded HER2 Diagnostic Test Indications
The test can now be used to identify HER2-positive metastatic breast cancer patients that could be eligible for Enhertu.
Breast
Latest
A Precision Oncology Approach Calls for Regular ESR1 Monitoring
Emerging liquid biopsy techniques enable sensitive, routine monitoring of ESR1 mutations in metastatic HR+ breast cancer.
HER2-ultralow Metastatic Breast Cancer Companion Diagnostic Approved by FDA
Roche’s PATHWAY anti-HER2/neu (4B5) test has received FDA approval to ID patients with HR-positive, HER2-ultralow metastatic breast cancer.
Read More
BioView Unveils Breakthrough Liquid Biopsy for HER2 Detection in Metastatic Breast Cancer
BioView’s liquid biopsy test offers a non-invasive method to detect HER2 status in metastatic breast cancer patients.
Read More
AI-Powered Blood Test Spots Earliest Sign of Breast Cancer
A new laser analysis and AI method capable of detecting stage 1a breast cancer with 98% accuracy offers an effective screening option.
Read More
New Genetic Breast Cancer Model Developed
A researcher’s new mouse model for studying breast cancer could enhance understanding of cancer metastasis and its spread to organs.
Read More
Alverno Labs Expands Practice of Ibex’s AI-Powered Cancer Diagnostics Platform
Alverno Laboratories has expanded its use of Ibex’s AI-powered cancer diagnostics platform to include breast cancer detection for patients.
Read More
Ibex Unveils Advancements in AI Breast Cancer Diagnostics Platform
Ibex has introduced advancements to its AI-powered platform, enhancing breast cancer diagnostics, improving algorithm accuracy, and more.
Read More
Many Breast Cancer Survivors Don’t Receive Genetic Testing, Despite Eligibility
Many breast cancer survivors who qualify for genetic testing are not receiving it, though those who do often discuss results with family.
Read More
New Blood Test Predicts Breast Cancer Recurrence Before Relapse
A new blood test can predict the recurrence of breast cancer in high-risk patients by detecting cancer DNA months or years before relapse.
Read More
PreciseDx Announces Poster Presentation for Breast Cancer Recurrence Test
PreciseDx will present findings on their AI-driven breast cancer recurrence prediction test at the 2024 ASCO Annual Meeting.
Read More
UCLA and PreciseDx Collaborate on AI-Powered Breast Cancer Recurrence Diagnostics
This collaborative study seeks to represent a significant step forward in digital pathology and oncology breast cancer research
Read More
Bio-Rad Launches Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection
Bio-Rad Laboratories launched its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit.Â
Read More
The Breast Cancer Index Test is Guiding Hormone Therapy Decisions
BCI testing is reshaping treatment decisions for early-stage HR+ breast cancer patients by helping guide endocrine therapy choices.
Read More
New Test Predicts Recurrence Rate in Early-Stage Invasive Breast Cancer Patients
The AidaBreast novel biosignature also predicts radiation therapy benefit for early-stage invasive breast cancer patients.
Read More
Why ESR1 Mutation Monitoring Can Keep One Step Ahead of Breast Cancer
For patients with metastatic HR+ breast cancer, there may be no test more important than monitoring for an ESR1 mutation.
Read More
Detecting Breast Cancer through a Spit Test
Scientists developed a saliva test that screens for breast cancer, which is showing promising results in experimental testing.
Read More